Form 8-K - Current report:
SEC Accession No. 0000912282-17-000062
Filing Date
2017-03-06
Accepted
2017-03-06 15:26:27
Documents
2
Period of Report
2017-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_030317.htm 8-K 24425
2 FORM OF PURCHASE AGREEMENT ex10_1.htm EX-10.1 131953
  Complete submission text file 0000912282-17-000062.txt   157612
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 17667701
SIC: 2834 Pharmaceutical Preparations